Glaxo To Buy Genelabs Technologies | November 3, 2008 Issue - Vol. 86 Issue 44 | Chemical & Engineering News
Volume 86 Issue 44 | p. 13 | Concentrates
Issue Date: November 3, 2008

Glaxo To Buy Genelabs Technologies

Department: Business

GlaxoSmithKline has reached a definitive agreement to buy Genelabs Technologies for $57 million. Genelabs is a Redwood City, Calif.-based drug discovery firm now focusing on novel compounds that selectively inhibit replication of the hepatitis C virus. The two firms already have a partnership to develop a vaccine against hepatitis E.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment